A

APYX

Apyx Medical Corporation Common Stock
$2.57
Current Price
AI analysis
Read what the AI thinks of Apyx Medical Corporation Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app

Key figures

Dividend per share
—
Yield
—
EPS
-$0.20
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings
Before the open · Expected EPS: -$0.10
Nov 5

Posts

No posts about APYX yet.

About Apyx Medical Corporation Common Stock

Apyx Medical is a small US medical device company. Its main product line, sold as Renuvion and J-Plasma, uses helium gas energy to tighten skin and cut soft tissue, mostly in cosmetic and plastic surgery. It earns money by selling the devices and the single-use handpieces that surgeons need for each procedure, and it also sells components to other medical companies.

Add APYX to your watchlist

Add APYX to your watchlist.
Scan with your iPhone camera: this page opens in the app.
  • Its AI analysis
  • Every story about it, live
  • An alert when a wallet trades it
Download on the App Store